1st JCA-AACR Precision Cancer Medicine International Conference
This Material* is presented at the 1st JCA-AACR Precision Cancer Medicine International Conference. Watch the video below to see our Chief Medical Officer, Dr. Robert Segal, present promising preliminary data from clinical trials investigating Immunopheresis® therapy for metastatic, refractory, solid tumor cancer patients who previously failed multiple lines of therapy. For more information read our press release.
*Shared here with permission from the Japanese Cancer Association (JCA).